OBJECTIVE: We studied the effects of weight loss induced by either a low-fat normal diet (ND) or restriction of high-fat diet (HFD) on hepatic steatosis, inflammation in the liver and adipose tissue (AT), and blood monocytes of obese mice. METHODS: In mice with HFD-induced obesity, weight loss was achieved by switching from HFD to ND and maintaining on ND ad libitum or by restricting HFD intake to match body weight of mice with ND-induced weight loss. After diet interventions for 4 weeks, hepatic steatosis, hepatic and AT inflammation, and blood CD11c(+) monocytes were examined. RESULTS: At 4 weeks after switching diets, body weight was reduced by 23% from baseline. To achieve the same reduced body weight required restricting calorie intake from HFD. Weight loss with either ND or HFD restriction decreased body fat mass and ameliorated liver steatosis; both effects were greater with ND-induced weight loss than HFD restriction-induced weight loss. Weight loss with ND but not HFD restriction normalized blood CD11c(+) monocytes and attenuated hepatic inflammation assessed by chemokine and CD11c expression. In contrast, weight loss with HFD restriction significantly reduced chemokine levels and CD11c(+) cells in AT compared to obese controls, and tended to reduce AT chemokines and CD11c(+) cells more than ND-induced weight loss. CONCLUSION: In mice with diet-induced obesity, weight loss with ND was superior in alleviating hepatic inflammation and steatosis, whereas weight loss with HFD calorie restriction provided greater amelioration of AT inflammation. Copyright Â
OBJECTIVE: We studied the effects of weight loss induced by either a low-fat normal diet (ND) or restriction of high-fat diet (HFD) on hepatic steatosis, inflammation in the liver and adipose tissue (AT), and blood monocytes of obesemice. METHODS: In mice with HFD-induced obesity, weight loss was achieved by switching from HFD to ND and maintaining on ND ad libitum or by restricting HFD intake to match body weight of mice with ND-induced weight loss. After diet interventions for 4 weeks, hepatic steatosis, hepatic and AT inflammation, and blood CD11c(+) monocytes were examined. RESULTS: At 4 weeks after switching diets, body weight was reduced by 23% from baseline. To achieve the same reduced body weight required restricting calorie intake from HFD. Weight loss with either ND or HFD restriction decreased body fat mass and ameliorated liver steatosis; both effects were greater with ND-induced weight loss than HFD restriction-induced weight loss. Weight loss with ND but not HFD restriction normalized blood CD11c(+) monocytes and attenuated hepatic inflammation assessed by chemokine and CD11c expression. In contrast, weight loss with HFD restriction significantly reduced chemokine levels and CD11c(+) cells in AT compared to obese controls, and tended to reduce AT chemokines and CD11c(+) cells more than ND-induced weight loss. CONCLUSION: In mice with diet-induced obesity, weight loss with ND was superior in alleviating hepatic inflammation and steatosis, whereas weight loss with HFD calorie restriction provided greater amelioration of AT inflammation. Copyright Â
Authors: P Flachs; V Mohamed-Ali; O Horakova; M Rossmeisl; M J Hosseinzadeh-Attar; M Hensler; J Ruzickova; J Kopecky Journal: Diabetologia Date: 2006-01-06 Impact factor: 10.122
Authors: Alan D Attie; Ronald M Krauss; Mark P Gray-Keller; Alison Brownlie; Makoto Miyazaki; John J Kastelein; Aldons J Lusis; Anton F H Stalenhoef; Jonathan P Stoehr; Michael R Hayden; James M Ntambi Journal: J Lipid Res Date: 2002-11 Impact factor: 5.922
Authors: Theophilus Owan; Erick Avelar; Kimberly Morley; Ronny Jiji; Nathaniel Hall; Joseph Krezowski; James Gallagher; Zachary Williams; Kevin Preece; Nancy Gundersen; Michael B Strong; Robert C Pendleton; Nathan Segerson; Tom V Cloward; James M Walker; Robert J Farney; Richard E Gress; Ted D Adams; Steven C Hunt; Sheldon E Litwin Journal: J Am Coll Cardiol Date: 2011-02-08 Impact factor: 24.094
Authors: J Y Kim; L A Nolte; P A Hansen; D H Han; K Ferguson; P A Thompson; J O Holloszy Journal: Am J Physiol Regul Integr Comp Physiol Date: 2000-12 Impact factor: 3.619
Authors: Stuart P Weisberg; Daniel McCann; Manisha Desai; Michael Rosenbaum; Rudolph L Leibel; Anthony W Ferrante Journal: J Clin Invest Date: 2003-12 Impact factor: 14.808
Authors: Jiali Wang; Xiaoyuan Dai Perrard; Jerry L Perrard; Aparna Mukherjee; Corina Rosales; Yuguo Chen; C Wayne Smith; Henry J Pownall; Christie M Ballantyne; Huaizhu Wu Journal: Atherosclerosis Date: 2012-06-19 Impact factor: 5.162
Authors: Laura M Cox; Ilseung Cho; Scott A Young; W H Kerr Anderson; Bartholomew J Waters; Shao-Ching Hung; Zhan Gao; Douglas Mahana; Monika Bihan; Alexander V Alekseyenko; Barbara A Methé; Martin J Blaser Journal: FASEB J Date: 2012-11-14 Impact factor: 5.191
Authors: Femke P M Hoevenaars; Jaap Keijer; Laure Herreman; Inge Palm; Maria A Hegeman; Hans J M Swarts; Evert M van Schothorst Journal: Genes Nutr Date: 2014-04-10 Impact factor: 5.523
Authors: Zeqin Lian; Xiao-Yuan Dai Perrard; Xueying Peng; Joe L Raya; Alfredo A Hernandez; Collin G Johnson; William R Lagor; Henry J Pownall; Ron C Hoogeveen; Scott I Simon; Frank M Sacks; Christie M Ballantyne; Huaizhu Wu Journal: Arterioscler Thromb Vasc Biol Date: 2019-10-17 Impact factor: 8.311
Authors: Frederick Wasinski; Reury F P Bacurau; Milton R Moraes; Anderson S Haro; Pedro M M Moraes-Vieira; Gabriel R Estrela; Edgar J Paredes-Gamero; Carlos C Barros; Sandro S Almeida; Niels O S Câmara; Ronaldo C Araujo Journal: Mediators Inflamm Date: 2013-03-13 Impact factor: 4.711